Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/18/2007
 
First Published:
7/1/2002
1.
Phase III Randomized Study of Bleomycin, Doxorubicin, Etoposide, Mechlorethamine, Vinblastine, Vincristine, and Prednisone (Stanford V) Versus Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) in Patients With Previously Untreated Advanced Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 to 60
Other
BNLI-STANFORDV
EU-20206, NCT00041210
2.
Therapy for Pediatric Hodgkin Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
21 and under
Other
HOD99
NCT00145600
3.
Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
Not specified
Pharmaceutical / Industry
2005NM-201-US
NCT00168064
Last Modified:
5/7/2008
 
First Published:
12/13/2007
4.
Phase II Study of Salvage Combination Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
13 to 65
NCI
MSKCC-07147
07-147, NCT00574496
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute